|
⚲
|
| Keyboard |
| Khuong Chau Quang
✚
|
|
|---|---|
| CIK # | 0001609405 |
| EDGAR Form | CIK | 2011 - 2026 |
|---|---|---|
| 3 | [0001609405] | |
| 4 | [0001609405] |
| Insider Transaction (Form 3/4/5) | Date | Action | Shares | Price | Value ($) |
|---|---|---|---|---|---|
|
NextCure Inc NXTC
Stock Option (Right to Buy) · derivative
|
2023-06-22 | Grant | 14,250 | $0.00 | |
|
Fusion Pharmaceuticals Inc FUSN
Stock Option (Right to Buy) · derivative
|
2023-06-14 | Grant | 17,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2023-06-14 | Grant | 18,000 | $0.00 | |
|
Fusion Pharmaceuticals Inc FUSN
Common Stock
|
2022-11-11 | Grant | 42,093 | $2.38 | 100,181 |
|
NextCure Inc NXTC
Stock Option (Right to Buy) · derivative
|
2022-06-23 | Grant | 14,250 | $0.00 | |
|
Damora Therapeutics Inc GLTO
/s/ Jonathan Freve, attorney-in-fact · derivative
|
2022-06-14 | Grant | 18,000 | $0.00 | |
|
Fusion Pharmaceuticals Inc FUSN
Stock Option (Right to Buy) · derivative
|
2022-06-14 | Grant | 17,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2021-11-17 | Grant | 9,000 | $0.00 | |
|
NextCure Inc NXTC
Stock Option (Right to Buy) · derivative
|
2021-06-24 | Grant | 14,250 | $0.00 | |
|
Fusion Pharmaceuticals Inc FUSN
Stock Option (Right to Buy) · derivative
|
2021-06-04 | Grant | 17,000 | $0.00 | |
|
Damora Therapeutics Inc GLTO
Stock Option (right to buy) · derivative
|
2021-05-26 | Grant | 18,000 | $0.00 | |
|
Synlogic Inc SYBX
Common Stock, $0.001 par value
|
2021-04-20 | Grant | 1,666,666 | $3.00 | 4,999,998 |
|
Damora Therapeutics Inc GLTO
Common Shares
|
2020-11-02 | Conversion | 822,311 | ||
|
Damora Therapeutics Inc GLTO
Common Shares
|
2020-11-02 | Buy | 209,500 | $15.00 | 3,142,500 |
|
Damora Therapeutics Inc GLTO
Common Shares
|
2020-11-02 | Buy | 523,833 | $15.00 | 7,857,495 |
|
Damora Therapeutics Inc GLTO
Common Shares
|
2020-11-02 | Conversion | 2,055,824 | ||
|
Damora Therapeutics Inc GLTO
Common Shares
|
2020-11-02 | Conversion | 191,787 | ||
|
Damora Therapeutics Inc GLTO
Series D Preferred Stock · derivative
|
2020-11-02 | Conversion | 59,350 | ||
|
Damora Therapeutics Inc GLTO
Series C-5 Preferred Stock · derivative
|
2020-11-02 | Conversion | 31,147 | ||
|
Damora Therapeutics Inc GLTO
Series C-5 Preferred Stock · derivative
|
2020-11-02 | Conversion | 77,866 | ||
| showing 20 of 128 most recent transactions | |||||